Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Thyroid Disorders
Is there a role for adding methotrexate to methimazole in the treatment of Graves' disease?
Related Questions
What are your thoughts on the possible correlation between Breast implants and thyroid autoimmune disorders / or thyroid cancer?
What doses of methimazole do you consider "low dose" when treating Graves' disease long-term?
When, if ever, is it appropriate to switch from generic levothyroxine to brand name Synthroid?
Is a target TSH closer to the mid normal range justified in older individuals (age 70 or above) without any known cardiac ischemia or dysrhythmia or osteoporosis?
What factors do you consider when deciding between RFA and surgery for a patient with a benign thyroid nodule causing dysphagia?
How do you counsel patients with elevated Thyroglobulin Peroxidase antibody levels, diffuse thyroiditis features on ultrasound, non-specific symptoms of fatigue, but normal biochemical thyroid function labs?
Are there specific populations with hypothyroidism for whom you would consider adding liothyronine to levothyroxine therapy, given observational data linking levothyroxine therapy alone to higher risks of dementia and mortality?
For patients on T4/T3 combination therapy for management of hypothyroidism is there an indication for monitoring T3 levels and if so, what is the appropriate timing (trough versus peak) given the pharmacokinetics of liothyronine?
How do you assess and adjust treatment in patients who develops hypothyroidism after being on lithium for several years?
For patients with low risk, differentiated thyroid cancer, how do you navigate the decision between less aggressive treatments, such as lobectomy alone without radioactive iodine, and more aggressive strategies?
